Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Accolade, Inc.

ACCDNASDAQ
Healthcare
Medical - Healthcare Information Services
$7.02
$0.00(0.00%)
U.S. Market is Open • 12:27

Accolade, Inc. (ACCD) Stock Overview

Explore Accolade, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap575.6M
P/E Ratio-3.90
EPS (TTM)$-2.28
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ACCD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Accolade, Inc. (ACCD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.90 and a market capitalization of 575.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.03%
6-Month Change
97.19%
Year-to-Date (YTD) Change
105.26%
1-Year Change
-1.40%
3-Year Change
28.81%
5-Year Change
1176.36%
All-Time (Max) Change
1176.36%

Contact Information

206 926 8100
660 West Germantown Pike, Plymouth Meeting, PA, 19462

Company Facts

24,000 Employees
IPO DateJul 1, 2020
CountryUS

Frequently Asked Questions